HSPG2 and cardiac hypertrophy: While the individual role of the different PLC isozymes in pathological cardiomyocyte growth still remains to be fully understood, from the information provided, it is apparent that PLC is an important contributor to the signaling processes leading to cardiac hypertrophy.